Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer risk in patients with alopecia areata: a nationwide population-based matched cohort study

Published:2018-03-25 Issue:5 Volume:7 Page:2153-2159
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen Chih-Chiang¹²³^ORCID,Chang Yun-Ting²³,Liu Han-Nan²³,Chen Yi-Ju¹²⁴

Affiliation:

1. Institute of Clinical Medicine; National Yang-Ming University; Taipei Taiwan

2. Department of Dermatology; National Yang-Ming University; Taipei Taiwan

3. Department of Dermatology; Taipei Veterans General Hospital; Taipei Taiwan

4. Department of Dermatology; Taichung Veterans General Hospital; Taichung Taiwan

Funder

Ministry of Science and Technology, Taiwan

TCVGH

Taipei Veterans General Hospital

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference40 articles.

1. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009;Mirzoyev;J. Invest. Dermatol.,2014

2. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989;Safavi;Mayo Clin. Proc.,1995

3. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity;Petukhova;Nature,2010

4. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack;Ito;J. Invest. Dermatol.,2008

5. Does the immune system see tumors as foreign or self?;Pardoll;Annu. Rev. Immunol.,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study;Frontiers in Medicine;2023-10-18

2. Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database;Dermatology and Therapy;2023-06-10

3. Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications;Advances in Therapy;2023-02-20

4. A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19;Advances in Therapy;2022-09-05

5. Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis;Frontiers in Oncology;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3